Regorafenib for previously treated metastatic colorectal cancer (mCRC): results from 683 Italian patients treated in the open-label phase IIIB CONSIGN study
Ciardiello, F., Salvatore, L., Cascinu, S., Sobrero, A., Banzi, M., Barone, C., Spallanzani, A., Latiano, T.L., Amatu, A., Zagonel, V., Biglietto, M., Di Costanzo, F., Di Bartolomeo, M., Santoro, A., Russo, A., Moscovici, M., Van Cutsem, E., Zaniboni, A.
Published in Annals of oncology (01.10.2015)
Published in Annals of oncology (01.10.2015)
Get full text
Journal Article